{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:07:12Z","timestamp":1771052832703,"version":"3.50.1"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12264-025-01498-x","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T08:43:26Z","timestamp":1760517806000},"page":"233-246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unveiling Butyrate as a Parkinson\u2019s Disease Therapy"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2363-8131","authenticated-orcid":false,"given":"Ant\u00f3nio E.","family":"Abreu","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8938-7560","authenticated-orcid":false,"given":"Nuno","family":"Empadinhas","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2199-0555","authenticated-orcid":false,"given":"Sandra Morais","family":"Cardoso","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"1498_CR1","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees AJ, Hardy J, Revesz T. Parkinson\u2019s disease. Lancet 2009, 373: 2055\u20132066.","journal-title":"Lancet"},{"key":"1498_CR2","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nrd2087","volume":"5","author":"AHV Schapira","year":"2006","unstructured":"Schapira AHV, Bezard E, Brotchie J, Calon F, Collingridge GL, Ferger B. Novel pharmacological targets for the treatment of Parkinson\u2019s disease. Nat Rev Drug Discov 2006, 5: 845\u2013854.","journal-title":"Nat Rev Drug Discov"},{"key":"1498_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40035-023-00392-8","volume":"12","author":"X Zhang","year":"2023","unstructured":"Zhang X, Tang B, Guo J. Parkinson\u2019s disease and gut microbiota: From clinical to mechanistic and therapeutic studies. Transl Neurodegener 2023, 12: 59.","journal-title":"Transl Neurodegener"},{"key":"1498_CR4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans F, Aho V, Pereira PAB, Koskinen K, Paulin L, Pekkonen E, et al. Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov Disord 2015, 30: 350\u2013358.","journal-title":"Mov Disord"},{"key":"1498_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13024-024-00766-0","volume":"19","author":"MF Munoz-Pinto","year":"2024","unstructured":"Munoz-Pinto MF, Candeias E, Melo-Marques I, Esteves AR, Maranha A, Magalh\u00e3es JD, et al. Gut-first Parkinson\u2019s disease is encoded by gut dysbiome. Mol Neurodegener 2024, 19: 78.","journal-title":"Mol Neurodegener"},{"key":"1498_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-019-02040-w","volume":"138","author":"N Van Den Berge","year":"2019","unstructured":"Van Den Berge N, Ferreira N, Gram H, Mikkelsen TW, Alstrup AKO, Casadei N, et al. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats. Acta Neuropathol 2019, 138: 535\u2013550.","journal-title":"Acta Neuropathol"},{"key":"1498_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12264-022-00934-6","volume":"39","author":"HN Costa","year":"2023","unstructured":"Costa HN, Esteves AR, Empadinhas N, Cardoso SM. Parkinson\u2019s disease: A multisystem disorder. Neurosci Bull 2023, 39: 113\u2013124.","journal-title":"Neurosci Bull"},{"key":"1498_CR8","doi-asserted-by":"publisher","first-page":"S371","DOI":"10.3233\/JPD-191802","volume":"9","author":"T Van Laar","year":"2019","unstructured":"Van Laar T, Boertien JM, Horta Herranz A. Faecal transplantation, pro- and prebiotics in Parkinson\u2019s disease; hope or hype? J Parkinsons Dis 2019, 9: S371\u2013S379.","journal-title":"J Parkinsons Dis"},{"key":"1498_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2021.111376","volume":"150","author":"Y Hou","year":"2021","unstructured":"Hou Y, Li X, Liu C, Zhang M, Zhang X, Ge S, et al. Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson\u2019s disease. Exp Gerontol 2021, 150: 111376.","journal-title":"Exp Gerontol"},{"key":"1498_CR10","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41467-023-36497-x","volume":"14","author":"DA Hall","year":"2023","unstructured":"Hall DA, Voigt RM, Cantu-Jungles TM, Hamaker B, Engen PA, Shaikh M, et al. An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson\u2019s disease participants. Nat Commun 2023, 14: 926.","journal-title":"Nat Commun"},{"key":"1498_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.immuni.2013.12.007","volume":"40","author":"N Singh","year":"2014","unstructured":"Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 2014, 40: 128\u2013139.","journal-title":"Immunity"},{"key":"1498_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ebiom.2018.03.030","volume":"30","author":"G Chen","year":"2018","unstructured":"Chen G, Ran X, Li B, Li Y, He D, Huang B, et al. Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model. EBioMedicine 2018, 30: 317\u2013325.","journal-title":"EBioMedicine"},{"key":"1498_CR13","doi-asserted-by":"publisher","first-page":"1099018","DOI":"10.3389\/fnagi.2023.1099018","volume":"15","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Xu S, Qian Y, Mo C, Ai P, Yang X, et al. Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson\u2019s disease by regulating gut microbiota. Front Aging Neurosci 2023, 15: 1099018.","journal-title":"Front Aging Neurosci"},{"key":"1498_CR14","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3390\/nu15040930","volume":"15","author":"TT Guo","year":"2023","unstructured":"Guo TT, Zhang Z, Sun Y, Zhu RY, Wang FX, Ma LJ, et al. Neuroprotective effects of sodium butyrate by restoring gut microbiota and inhibiting TLR4 signaling in mice with MPTP-induced Parkinson\u2019s disease. Nutrients 2023, 15: 930.","journal-title":"Nutrients"},{"key":"1498_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","volume":"17","author":"D Berg","year":"2021","unstructured":"Berg D, Borghammer P, Fereshtehnejad SM, Heinzel S, Horsager J, Schaeffer E, et al. Prodromal parkinson disease subtypes\u2014Key to understanding heterogeneity. Nat Rev Neurol 2021, 17: 349\u2013361.","journal-title":"Nat Rev Neurol"},{"key":"1498_CR16","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/brain\/awaa238","volume":"143","author":"J Horsager","year":"2020","unstructured":"Horsager J, Andersen KB, Knudsen K, Skj\u00e6rb\u00e6k C, Fedorova TD, Okkels N, et al. Brain-first versus body-first Parkinson\u2019s disease: A multimodal imaging case-control study. Brain 2020, 143: 3077\u20133088.","journal-title":"Brain"},{"key":"1498_CR17","doi-asserted-by":"publisher","first-page":"106101","DOI":"10.1016\/j.parkreldis.2024.106101","volume":"122","author":"J Horsager","year":"2024","unstructured":"Horsager J, Borghammer P. Brain-first vs. body-first Parkinson\u2019s disease: An update on recent evidence. Parkinsonism Relat Disord 2024, 122: 106101.","journal-title":"Parkinsonism Relat Disord"},{"key":"1498_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41531-024-00730-1","volume":"10","author":"Z Xu","year":"2024","unstructured":"Xu Z, Hu T, Xu C, Liang X, Li S, Sun Y, et al. Disease progression in proposed brain-first and body-first Parkinson\u2019s disease subtypes. NPJ Parkinsons Dis 2024, 10: 111.","journal-title":"NPJ Parkinsons Dis"},{"key":"1498_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41531-023-00554-5","volume":"9","author":"P Huang","year":"2023","unstructured":"Huang P, Zhang P, Du J, Gao C, Liu J, Tan Y, et al. Association of fecal short-chain fatty acids with clinical severity and gut microbiota in essential tremor and its difference from Parkinson\u2019s disease. NPJ Parkinsons Dis 2023, 9: 115.","journal-title":"NPJ Parkinsons Dis"},{"key":"1498_CR20","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/mds.29063","volume":"37","author":"X Yang","year":"2022","unstructured":"Yang X, Ai P, He X, Mo C, Zhang Y, Xu S, et al. Parkinson\u2019s disease is associated with impaired gut-blood barrier for short-chain fatty acids. Mov Disord 2022, 37: 1634\u20131643.","journal-title":"Mov Disord"},{"key":"1498_CR21","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41575-020-0339-z","volume":"17","author":"R Alberto Travagli","year":"2020","unstructured":"Alberto Travagli R, Browning KN, Camilleri M. Parkinson disease and the gut: New insights into pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol 2020, 17: 673\u2013685.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1498_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.689723","volume":"15","author":"L Dumitrescu","year":"2021","unstructured":"Dumitrescu L, Marta D, D\u0103n\u0103u A, Lefter A, Tulb\u0103 D, Cozma L, et al. Serum and fecal markers of intestinal inflammation and intestinal barrier permeability are elevated in Parkinson\u2019s disease. Front Neurosci 2021, 15: 689723.","journal-title":"Front Neurosci"},{"key":"1498_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-015-0196-0","volume":"3","author":"T Clairembault","year":"2015","unstructured":"Clairembault T, Leclair-Visonneau L, Coron E, Bourreille A, Le Dily S, Vavasseur F, et al. Structural alterations of the intestinal epithelial barrier in Parkinson\u2019s disease. Acta Neuropathol Commun 2015, 3: 12.","journal-title":"Acta Neuropathol Commun"},{"key":"1498_CR24","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1007\/s11064-018-2620-x","volume":"43","author":"F Lai","year":"2018","unstructured":"Lai F, Jiang R, Xie W, Liu X, Tang Y, Xiao H, et al. Intestinal pathology and gut microbiota alterations in a methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) mouse model of Parkinson\u2019s disease. Neurochem Res 2018, 43: 1986\u20131999.","journal-title":"Neurochem Res"},{"key":"1498_CR25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3233\/JPD-202481","volume":"11","author":"P Borghammer","year":"2021","unstructured":"Borghammer P. The \u03b1-synuclein origin and connectome model (SOC model) of Parkinson\u2019s disease: Explaining motor asymmetry, non-motor phenotypes, and cognitive decline. J Parkinsons Dis 2021, 11: 455\u2013474.","journal-title":"J Parkinsons Dis"},{"key":"1498_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, et al. Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron 2019, 103: 627-641.e7.","journal-title":"Neuron"},{"key":"1498_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/gutjnl-2021-326023","volume":"72","author":"AR Esteves","year":"2023","unstructured":"Esteves AR, Munoz-Pinto MF, Nunes-Costa D, Candeias E, Silva DF, Magalh\u00e3es JD, et al. Footprints of a microbial toxin from the gut microbiome to mesencephalic mitochondria. Gut 2023, 72: 73\u201389.","journal-title":"Gut"},{"key":"1498_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2018.12.012","volume":"135","author":"HB Dodiya","year":"2020","unstructured":"Dodiya HB, Forsyth CB, Voigt RM, Engen PA, Patel J, Shaikh M, et al. Chronic stress-induced gut dysfunction exacerbates Parkinson\u2019s disease phenotype and pathology in a rotenone-induced mouse model of Parkinson\u2019s disease. Neurobiol Dis 2020, 135: 104352.","journal-title":"Neurobiol Dis"},{"key":"1498_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13024-021-00427-6","volume":"16","author":"VTE Aho","year":"2021","unstructured":"Aho VTE, Houser MC, Pereira PAB, Chang J, Rudi K, Paulin L, et al. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson\u2019s disease. Mol Neurodegener 2021, 16: 6.","journal-title":"Mol Neurodegener"},{"key":"1498_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","volume":"7","author":"DJ Morrison","year":"2016","unstructured":"Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 2016, 7: 189\u2013200.","journal-title":"Gut Microbes"},{"key":"1498_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cellimm.2018.03.003","volume":"328","author":"ED Hu","year":"2018","unstructured":"Hu ED, Chen DZ, Wu JL, Lu FB, Chen L, Zheng MH, et al. High fiber dietary and sodium butyrate attenuate experimental autoimmune hepatitis through regulation of immune regulatory cells and intestinal barrier. Cell Immunol 2018, 328: 24\u201332.","journal-title":"Cell Immunol"},{"key":"1498_CR32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41423-023-00987-1","volume":"20","author":"CH Kim","year":"2023","unstructured":"Kim CH. Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity. Cell Mol Immunol 2023, 20: 341\u2013350.","journal-title":"Cell Mol Immunol"},{"key":"1498_CR33","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/molehr\/gaaa025","volume":"26","author":"HEC Moylan","year":"2020","unstructured":"Moylan HEC, Nguyen-Ngo C, Lim R, Lappas M. The short-chain fatty acids butyrate and propionate protect against inflammation-induced activation of mediators involved in active labor: Implications for preterm birth. Mol Hum Reprod 2020, 26: 452\u2013468.","journal-title":"Mol Hum Reprod"},{"key":"1498_CR34","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S0016-5085(00)70142-9","volume":"118","author":"MS Inan","year":"2000","unstructured":"Inan MS, Rasoulpour RJ, Yin L, Hubbard AK, Rosenberg DW, Giardina C. The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology 2000, 118: 724\u2013734.","journal-title":"Gastroenterology"},{"key":"1498_CR35","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3389\/fimmu.2015.00554","volume":"6","author":"MY Lin","year":"2015","unstructured":"Lin MY, de Zoete MR, van Putten JPM, Strijbis K. Redirection of epithelial immune responses by short-chain fatty acids through inhibition of histone deacetylases. Front Immunol 2015, 6: 554.","journal-title":"Front Immunol"},{"key":"1498_CR36","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.3389\/fimmu.2017.01108","volume":"8","author":"J Wang","year":"2017","unstructured":"Wang J, Wei Z, Zhang X, Wang Y, Yang Z, Fu Y. Propionate protects against lipopolysaccharide-induced mastitis in mice by restoring blood-milk barrier disruption and suppressing inflammatory response. Front Immunol 2017, 8: 1108.","journal-title":"Front Immunol"},{"key":"1498_CR37","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/nu13010028","volume":"13","author":"TB Karunaratne","year":"2020","unstructured":"Karunaratne TB, Okereke C, Seamon M, Purohit S, Wakade C, Sharma A. Niacin and butyrate: Nutraceuticals targeting dysbiosis and intestinal permeability in Parkinson\u2019s disease. Nutrients 2020, 13: 28.","journal-title":"Nutrients"},{"key":"1498_CR38","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1073\/pnas.1322269111","volume":"111","author":"PV Chang","year":"2014","unstructured":"Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA 2014, 111: 2247\u20132252.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1498_CR39","doi-asserted-by":"publisher","first-page":"e00243","DOI":"10.1128\/mSphere.00243-17","volume":"2","author":"JA Jiminez","year":"2017","unstructured":"Jiminez JA, Uwiera TC, Wade Abbott D, Uwiera RRE. Douglas Inglis G. Butyrate supplementation at high concentrations alters enteric bacterial communities and reduces intestinal inflammation in mice infected with Citrobacter rodentium. mSphere 2017, 2: e00243-e317.","journal-title":"mSphere"},{"key":"1498_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13914","volume":"32","author":"S Facchin","year":"2020","unstructured":"Facchin S, Vitulo N, Calgaro M, Buda A, Romualdi C, Pohl D, et al. Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease. Neurogastroenterol Motil 2020, 32: e13914.","journal-title":"Neurogastroenterol Motil"},{"key":"1498_CR41","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 2016, 167: 1469-1480.e12.","journal-title":"Cell"},{"key":"1498_CR42","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.cell.2020.02.035","volume":"180","author":"A Duscha","year":"2020","unstructured":"Duscha A, Gisevius B, Hirschberg S, Yissachar N, Stangl GI, Dawin E, et al. Propionic acid shapes the multiple sclerosis disease course by an immunomodulatory mechanism. Cell 2020, 180: 1067-1080.e16.","journal-title":"Cell"},{"key":"1498_CR43","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1161\/CIRCRESAHA.119.316448","volume":"127","author":"J Lee","year":"2020","unstructured":"Lee J, d\u2019Aigle J, Atadja L, Quaicoe V, Honarpisheh P, Ganesh BP, et al. Gut microbiota-derived short-chain fatty acids promote poststroke recovery in aged mice. Circ Res 2020, 127: 453\u2013465.","journal-title":"Circ Res"},{"key":"1498_CR44","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"G den Besten","year":"2013","unstructured":"den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 2013, 54: 2325\u20132340.","journal-title":"J Lipid Res"},{"key":"1498_CR45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.femsec.2005.03.012","volume":"54","author":"M Wang","year":"2005","unstructured":"Wang M, Ahrn\u00e9 S, Jeppsson B, Molin G. Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes. FEMS Microbiol Ecol 2005, 54: 219\u2013231.","journal-title":"FEMS Microbiol Ecol"},{"key":"1498_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105174","volume":"160","author":"SC Bridgeman","year":"2020","unstructured":"Bridgeman SC, Northrop W, Melton PE, Ellison GC, Newsholme P, Mamotte CDS. Butyrate generated by gut microbiota and its therapeutic role in metabolic syndrome. Pharmacol Res 2020, 160: 105174.","journal-title":"Pharmacol Res"},{"key":"1498_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1826748","volume":"12","author":"M Lenoir","year":"2020","unstructured":"Lenoir M, Mart\u00edn R, Torres-Maravilla E, Chadi S, Gonz\u00e1lez-D\u00e1vila P, Sokol H, et al. Butyrate mediates anti-inflammatory effects of Faecalibacterium prausnitzii in intestinal epithelial cells through Dact3. Gut Microbes 2020, 12: 1\u201316.","journal-title":"Gut Microbes"},{"key":"1498_CR48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1017\/S0029665120006916","volume":"80","author":"C Martin-Gallausiaux","year":"2021","unstructured":"Martin-Gallausiaux C, Marinelli L, Blotti\u00e8re HM, Larraufie P, Lapaque N. SCFA: Mechanisms and functional importance in the gut. Proc Nutr Soc 2021, 80: 37\u201349.","journal-title":"Proc Nutr Soc"},{"key":"1498_CR49","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol 2019, 16: 461\u2013478.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1498_CR50","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.2174\/138945012804545443","volume":"13","author":"R Heidor","year":"2012","unstructured":"Heidor R, Ortega JF, de Conti A, Ong TP, Moreno FS. Anticarcinogenic actions of tributyrin, a butyric acid prodrug. Curr Drug Targets 2012, 13: 1720\u20131729.","journal-title":"Curr Drug Targets"},{"key":"1498_CR51","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1111\/all.14625","volume":"76","author":"L Paparo","year":"2021","unstructured":"Paparo L, Nocerino R, Ciaglia E, Di Scala C, De Caro C, Russo R, et al. Butyrate as a bioactive human milk protective component against food allergy. Allergy 2021, 76: 1398\u20131415.","journal-title":"Allergy"},{"key":"1498_CR52","doi-asserted-by":"publisher","first-page":"7317","DOI":"10.1021\/jm500640x","volume":"57","author":"H Wang","year":"2014","unstructured":"Wang H, Yang C, Doherty JR, Roush WR, Cleveland JL, Bannister TD. Synthesis and structure-activity relationships of pteridine Dione and trione monocarboxylate transporter 1 inhibitors. J Med Chem 2014, 57: 7317\u20137324.","journal-title":"J Med Chem"},{"key":"1498_CR53","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.neuint.2016.06.011","volume":"99","author":"RM Stilling","year":"2016","unstructured":"Stilling RM, van de Wouw M, Clarke G, Stanton C, Dinan TG, Cryan JF. The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis? Neurochem Int 2016, 99: 110\u2013132.","journal-title":"Neurochem Int"},{"key":"1498_CR54","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.neuroscience.2013.04.037","volume":"246","author":"R St Laurent","year":"2013","unstructured":"St Laurent R, O\u2019Brien LM, Ahmad ST. Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson\u2019s disease. Neuroscience 2013, 246: 382\u2013390.","journal-title":"Neuroscience"},{"key":"1498_CR55","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/brainsci12050672","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Gu Z, Lin S, Chen L, Dzreyan V, Eid M, et al. Histone deacetylases as epigenetic targets for treating Parkinson\u2019s disease. Brain Sci 2022, 12: 672.","journal-title":"Brain Sci"},{"key":"1498_CR56","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/hmg\/ddx114","volume":"26","author":"I Paiva","year":"2017","unstructured":"Paiva I, Pinho R, Pavlou MA, Hennion M, Wales P, Sch\u00fctz AL, et al. Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage. Hum Mol Genet 2017, 26: 2231\u20132246.","journal-title":"Hum Mol Genet"},{"key":"1498_CR57","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/advances\/nmx009","volume":"9","author":"H Liu","year":"2018","unstructured":"Liu H, Wang J, He T, Becker S, Zhang G, Li D, et al. Butyrate: A double-edged sword for health? Adv Nutr 2018, 9: 21\u201329.","journal-title":"Adv Nutr"},{"key":"1498_CR58","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D, De la Fuente MK, Landskron G, Gonz\u00e1lez MJ, Quera R, Dijkstra G, et al. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol 2019, 10: 277.","journal-title":"Front Immunol"},{"key":"1498_CR59","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1161\/CIRCRESAHA.122.320184","volume":"131","author":"HB Li","year":"2022","unstructured":"Li HB, Xu ML, Xu XD, Tang YY, Jiang HL, Li L, et al. Faecalibacterium prausnitzii attenuates CKD via butyrate-renal GPR43 axis. Circ Res 2022, 131: e120\u2013e134.","journal-title":"Circ Res"},{"key":"1498_CR60","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41598-019-56743-x","volume":"10","author":"S Ducastel","year":"2020","unstructured":"Ducastel S, Touche V, Trabelsi MS, Boulinguiez A, Butruille L, Nawrot M, et al. The nuclear receptor FXR inhibits Glucagon-Like Peptide-1 secretion in response to microbiota-derived Short-Chain Fatty Acids. Sci Rep 2020, 10: 174.","journal-title":"Sci Rep"},{"key":"1498_CR61","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2337\/db11-1019","volume":"61","author":"G Tolhurst","year":"2012","unstructured":"Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 2012, 61: 364\u2013371.","journal-title":"Diabetes"},{"key":"1498_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0183-1","volume":"50","author":"D Zhou","year":"2018","unstructured":"Zhou D, Chen YW, Zhao ZH, Yang RX, Xin FZ, Liu XL, et al. Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression. Exp Mol Med 2018, 50: 1\u201312.","journal-title":"Exp Mol Med"},{"key":"1498_CR63","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jns.2017.08.3235","volume":"381","author":"J Liu","year":"2017","unstructured":"Liu J, Wang F, Liu S, Du J, Hu X, Xiong J, et al. Sodium butyrate exerts protective effect against Parkinson\u2019s disease in mice via stimulation of glucagon like peptide-1. J Neurol Sci 2017, 381: 176\u2013181.","journal-title":"J Neurol Sci"},{"key":"1498_CR64","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1038\/sj.jid.5700586","volume":"126","author":"D Maciejewski-Lenoir","year":"2006","unstructured":"Maciejewski-Lenoir D, Richman JG, Hakak Y, Gaidarov I, Behan DP, Connolly DT. Langerhans cells release prostaglandin D2 in response to nicotinic acid. J Invest Dermatol 2006, 126: 2637\u20132646.","journal-title":"J Invest Dermatol"},{"key":"1498_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109818","volume":"9","author":"C Wakade","year":"2014","unstructured":"Wakade C, Chong R, Bradley E, Thomas B, Morgan J. Upregulation of GPR109A in Parkinson\u2019s disease. PLoS One 2014, 9: e109818.","journal-title":"PLoS One"},{"key":"1498_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.875473","volume":"9","author":"X Li","year":"2022","unstructured":"Li X, Li R, You N, Zhao X, Li J, Jiang W. Butyric acid ameliorates myocardial fibrosis by regulating M1\/M2 polarization of macrophages and promoting recovery of mitochondrial function. Front Nutr 2022, 9: 875473.","journal-title":"Front Nutr"},{"key":"1498_CR67","doi-asserted-by":"publisher","first-page":"e0198723","DOI":"10.1128\/mbio.01987-23","volume":"14","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Sun H, Chen Y, Niu Q, Dong Y, Li M, et al. Butyrate protects against MRSA pneumonia via regulating gut-lung microbiota and alveolar macrophage M2 polarization. mBio 2023, 14: e0198723.","journal-title":"mBio"},{"key":"1498_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-021-02201-4","volume":"41","author":"Y Chen","year":"2022","unstructured":"Chen Y, Liu Y, Wang Y, Chen X, Wang C, Chen X, et al. Prevotellaceae produces butyrate to alleviate PD-1\/PD-L1 inhibitor-related cardiotoxicity via PPAR\u03b1-CYP4X1 axis in colonic macrophages. J Exp Clin Cancer Res 2022, 41: 1.","journal-title":"J Exp Clin Cancer Res"},{"key":"1498_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154209","volume":"103","author":"MR Kim","year":"2022","unstructured":"Kim MR, Cho SY, Lee HJ, Kim JY, Nguyen UTT, Ha NM, et al. Schisandrin C improves leaky gut conditions in intestinal cell monolayer, organoid, and nematode models by increasing tight junction protein expression. Phytomedicine 2022, 103: 154209.","journal-title":"Phytomedicine"},{"key":"1498_CR70","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1159\/000490981","volume":"47","author":"W Feng","year":"2018","unstructured":"Feng W, Wu Y, Chen G, Fu S, Li B, Huang B, et al. Sodium butyrate attenuates diarrhea in weaned piglets and promotes tight junction protein expression in colon in a GPR109A-dependent manner. Cell Physiol Biochem 2018, 47: 1617\u20131629.","journal-title":"Cell Physiol Biochem"},{"key":"1498_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179586","volume":"12","author":"H Yan","year":"2017","unstructured":"Yan H, Ajuwon KM. Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway. PLoS One 2017, 12: e0179586.","journal-title":"PLoS One"},{"key":"1498_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0269872","volume":"17","author":"TH Jung","year":"2022","unstructured":"Jung TH, Han KS, Park JH, Hwang HJ. Butyrate modulates mucin secretion and bacterial adherence in LoVo cells via MAPK signaling. PLoS One 2022, 17: e0269872.","journal-title":"PLoS One"},{"key":"1498_CR73","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.bbrc.2007.03.025","volume":"356","author":"H Hatayama","year":"2007","unstructured":"Hatayama H, Iwashita J, Kuwajima A, Abe T. The short chain fatty acid, butyrate, stimulates MUC2 mucin production in the human colon cancer cell line, LS174T. Biochem Biophys Res Commun 2007, 356: 599\u2013603.","journal-title":"Biochem Biophys Res Commun"},{"key":"1498_CR74","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.14336\/AD.2021.0418","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Chen Y, Jiang L, Zhang J, Tong X, Chen D, et al. Intestinal inflammation and Parkinson\u2019s disease. Aging Dis 2021, 12: 2052\u20132068.","journal-title":"Aging Dis"},{"key":"1498_CR75","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","volume":"50","author":"D Devos","year":"2013","unstructured":"Devos D, Lebouvier T, Lardeux B, Biraud M, Rouaud T, Pouclet H, et al. Colonic inflammation in Parkinson\u2019s disease. Neurobiol Dis 2013, 50: 42\u201348.","journal-title":"Neurobiol Dis"},{"key":"1498_CR76","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41531-016-0002-0","volume":"3","author":"MC Houser","year":"2017","unstructured":"Houser MC, Tansey MG. The gut-brain axis: Is intestinal inflammation a silent driver of Parkinson\u2019s disease pathogenesis? NPJ Park Dis 2017, 3: 3.","journal-title":"NPJ Park Dis"},{"key":"1498_CR77","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/mds.27581","volume":"34","author":"M Barichella","year":"2019","unstructured":"Barichella M, Severgnini M, Cilia R, Cassani E, Bolliri C, Caronni S, et al. Unraveling gut microbiota in Parkinson\u2019s disease and atypical Parkinsonism. Mov Disord 2019, 34: 396\u2013405.","journal-title":"Mov Disord"},{"key":"1498_CR78","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","volume":"32","author":"EM Hill-Burns","year":"2017","unstructured":"Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, et al. Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome. Mov Disord 2017, 32: 739\u2013749.","journal-title":"Mov Disord"},{"key":"1498_CR79","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic J, Tan EK. Parkinson\u2019s disease: Etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 2020, 91: 795\u2013808.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1498_CR80","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger MM, Spiegel J, Dillmann KU, Grundmann D, Philippeit H, B\u00fcrmann J, et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat Disord 2016, 32: 66\u201372.","journal-title":"Parkinsonism Relat Disord"},{"key":"1498_CR81","doi-asserted-by":"publisher","first-page":"e848","DOI":"10.1212\/WNL.0000000000013225","volume":"98","author":"SJ Chen","year":"2022","unstructured":"Chen SJ, Chen CC, Liao HY, Lin YT, Wu YW, Liou JM, et al. Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with parkinson disease. Neurology 2022, 98: e848\u2013e858.","journal-title":"Neurology"},{"key":"1498_CR82","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1002\/mds.29128","volume":"37","author":"A Xie","year":"2022","unstructured":"Xie A, Ensink E, Li P, Gordevi\u010dius J, Marshall LL, George S, et al. Bacterial butyrate in Parkinson\u2019s disease is linked to epigenetic changes and depressive symptoms. Mov Disord 2022, 37: 1644\u20131653.","journal-title":"Mov Disord"},{"key":"1498_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028032","volume":"6","author":"CB Forsyth","year":"2011","unstructured":"Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS One 2011, 6: e28032.","journal-title":"PLoS One"},{"key":"1498_CR84","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/kjm2.12745","volume":"39","author":"LL Ji","year":"2023","unstructured":"Ji LL, Huang TT, Mao LL, Xu YF, Chen WY, Wang WW, et al. The gut microbiota metabolite butyrate mitigates MPTP\/MPP+-induced Parkinson\u2019s disease by inhibiting the JAK2\/STAT3 signaling pathway. Kaohsiung J Med Sci 2023, 39: 1002\u20131010.","journal-title":"Kaohsiung J Med Sci"},{"key":"1498_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197946","volume":"13","author":"MST Mapa","year":"2018","unstructured":"Mapa MST, Le VQ, Wimalasena K. Characteristics of the mitochondrial and cellular uptake of MPP+, as probed by the fluorescent mimic, 4\u2019I-MPP. PLoS One 2018, 13: e0197946.","journal-title":"PLoS One"},{"key":"1498_CR86","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.brainres.2010.07.041","volume":"1354","author":"SK Kidd","year":"2010","unstructured":"Kidd SK, Schneider JS. Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition. Brain Res 2010, 1354: 172\u2013178.","journal-title":"Brain Res"},{"key":"1498_CR87","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3389\/fphar.2020.00537","volume":"11","author":"S Shukla","year":"2020","unstructured":"Shukla S, Tekwani BL. Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation. Front Pharmacol 2020, 11: 537.","journal-title":"Front Pharmacol"},{"key":"1498_CR88","first-page":"226","volume":"4","author":"R Schilderink","year":"2013","unstructured":"Schilderink R, Verseijden C, de Jonge WJ. Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis. Front Immunol 2013, 4: 226.","journal-title":"Front Immunol"},{"key":"1498_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2021.147749","volume":"1776","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Xu S, Qian Y, He X, Mo C, Yang X, et al. Sodium butyrate attenuates rotenone-induced toxicity by activation of autophagy through epigenetically regulating PGC-1\u03b1 expression in PC12 cells. Brain Res 2022, 1776: 147749.","journal-title":"Brain Res"},{"key":"1498_CR90","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1194","volume":"12","author":"Y Xu","year":"2024","unstructured":"Xu Y, Wen L, Tang Y, Zhao Z, Xu M, Wang T, et al. Sodium butyrate activates the KATP channels to regulate the mechanism of Parkinson\u2019s disease microglia model inflammation. Immun Inflamm Dis 2024, 12: e1194.","journal-title":"Immun Inflamm Dis"},{"key":"1498_CR91","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1007\/s11064-020-03074-3","volume":"45","author":"CM Qiao","year":"2020","unstructured":"Qiao CM, Sun MF, Jia XB, Li Y, Zhang BP, Zhao LP, et al. Sodium butyrate exacerbates Parkinson\u2019s disease by aggravating neuroinflammation and colonic inflammation in MPTP-induced mice model. Neurochem Res 2020, 45: 2128\u20132142.","journal-title":"Neurochem Res"},{"key":"1498_CR92","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1016\/j.neuropharm.2012.01.026","volume":"62","author":"P Rane","year":"2012","unstructured":"Rane P, Shields J, Heffernan M, Guo Y, Akbarian S, King JA. The histone deacetylase inhibitor, sodium butyrate, alleviates cognitive deficits in pre-motor stage PD. Neuropharmacology 2012, 62: 2409\u20132412.","journal-title":"Neuropharmacology"},{"key":"1498_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.117903","volume":"184","author":"C Avagliano","year":"2025","unstructured":"Avagliano C, De Caro C, Cuozzo M, Roberti R, Russo E, Rana GL, et al. Sodium Butyrate ameliorates pain and mood disorders in a mouse model of Parkinson disease. Biomed Pharmacother 2025, 184: 117903.","journal-title":"Biomed Pharmacother"},{"key":"1498_CR94","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.81453","volume":"11","author":"R Abdel-Haq","year":"2022","unstructured":"Abdel-Haq R, Schlachetzki JCM, Boktor JC, Cantu-Jungles TM, Thron T, Zhang M, et al. A prebiotic diet modulates microglial states and motor deficits in \u03b1-synuclein overexpressing mice. Elife 2022, 11: e81453.","journal-title":"Elife"},{"key":"1498_CR95","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jnutbio.2019.03.021","volume":"69","author":"S Srivastav","year":"2019","unstructured":"Srivastav S, Neupane S, Bhurtel S, Katila N, Maharjan S, Choi H, et al. Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity. J Nutr Biochem 2019, 69: 73\u201386.","journal-title":"J Nutr Biochem"},{"key":"1498_CR96","doi-asserted-by":"publisher","first-page":"pyu032","DOI":"10.1093\/ijnp\/pyu032","volume":"18","author":"Y Wei","year":"2014","unstructured":"Wei Y, Melas PA, Wegener G, Math\u00e9 AA, Lavebratt C. Antidepressant-like effect of sodium butyrate is associated with an increase in TET1 and in 5-hydroxymethylation levels in the Bdnf gene. Int J Neuropsychopharmacol 2014, 18: pyu032.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1498_CR97","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.3390\/nu14214678","volume":"14","author":"T Li","year":"2022","unstructured":"Li T, Chu C, Yu L, Zhai Q, Wang S, Zhao J, et al. Neuroprotective effects of Bifidobacterium breve CCFM1067 in MPTP-induced mouse models of Parkinson\u2019s disease. Nutrients 2022, 14: 4678.","journal-title":"Nutrients"},{"key":"1498_CR98","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1203\/01.pdr.0000250014.92242.f3","volume":"61","author":"L Peng","year":"2007","unstructured":"Peng L, He Z, Chen W, Holzman IR, Lin J. Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr Res 2007, 61: 37\u201341.","journal-title":"Pediatr Res"},{"key":"1498_CR99","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1017\/S0043933916000210","volume":"72","author":"U Ahsan","year":"2016","unstructured":"Ahsan U, Cengiz RI, Kuter E, Chacher MFA, Iqbal Z, et al. Sodium butyrate in chicken nutrition: The dynamics of performance, gut microbiota, gut morphology, and immunity. World\u2019s Poult Sci J 2016, 72: 265\u2013275.","journal-title":"World\u2019s Poult Sci J"},{"key":"1498_CR100","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.anifeedsci.2006.03.017","volume":"132","author":"Z Hu","year":"2007","unstructured":"Hu Z, Guo Y. Effects of dietary sodium butyrate supplementation on the intestinal morphological structure, absorptive function and gut flora in chickens. Anim Feed Sci Technol 2007, 132: 240\u2013249.","journal-title":"Anim Feed Sci Technol"},{"key":"1498_CR101","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.1002\/jsfa.13288","volume":"104","author":"H Gao","year":"2024","unstructured":"Gao H, Zhao X, Guo Y, Li Z, Zhou Z. Coated sodium butyrate and vitamin D3 supplementation improve gut health through influencing intestinal immunity, barrier, and microflora in early-stage broilers. J Sci Food Agric 2024, 104: 4058\u20134069.","journal-title":"J Sci Food Agric"},{"key":"1498_CR102","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/carcin\/bgr254","volume":"33","author":"JM Clarke","year":"2012","unstructured":"Clarke JM, Young GP, Topping DL, Bird AR, Cobiac L, Scherer BL, et al. Butyrate delivered by butyrylated starch increases distal colonic epithelial apoptosis in carcinogen-treated rats. Carcinogenesis 2012, 33: 197\u2013202.","journal-title":"Carcinogenesis"},{"key":"1498_CR103","doi-asserted-by":"publisher","first-page":"1388401","DOI":"10.3389\/fphar.2024.1388401","volume":"15","author":"JD Elford","year":"2024","unstructured":"Elford JD, Becht N, Garssen J, Kraneveld AD, Perez-Pardo P. Buty and the beast: The complex role of butyrate in Parkinson\u2019s disease. Front Pharmacol 2024, 15: 1388401.","journal-title":"Front Pharmacol"},{"key":"1498_CR104","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1212\/WNL.0000000000003127","volume":"87","author":"M Barichella","year":"2016","unstructured":"Barichella M, Pacchetti C, Bolliri C, Cassani E, Iorio L, Pusani C, et al. Probiotics and prebiotic fiber for constipation associated with Parkinson disease: An RCT. Neurology 2016, 87: 1274\u20131280.","journal-title":"Neurology"},{"key":"1498_CR105","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.parkreldis.2022.08.022","volume":"103","author":"Y Du","year":"2022","unstructured":"Du Y, Li Y, Xu X, Li R, Zhang M, Cui Y, et al. Probiotics for constipation and gut microbiota in Parkinson\u2019s disease. Parkinsonism Relat Disord 2022, 103: 92\u201397.","journal-title":"Parkinsonism Relat Disord"},{"key":"1498_CR106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244680","volume":"15","author":"A Ibrahim","year":"2020","unstructured":"Ibrahim A, Ali RAR, Manaf MRA, Ahmad N, Tajurruddin FW, Qin WZ, et al. Multi-strain probiotics (Hexbio) containing MCP BCMC strains improved constipation and gut motility in Parkinson\u2019s disease: A randomised controlled trial. PLoS One 2020, 15: e0244680.","journal-title":"PLoS One"},{"key":"1498_CR107","doi-asserted-by":"publisher","first-page":"e772","DOI":"10.1212\/WNL.0000000000010998","volume":"96","author":"AH Tan","year":"2021","unstructured":"Tan AH, Lim SY, Chong KK, Manap MAA, Hor JW, Lim JL, et al. Probiotics for constipation in parkinson disease: A randomized placebo-controlled study. Neurology 2021, 96: e772\u2013e782.","journal-title":"Neurology"},{"key":"1498_CR108","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.clnu.2018.05.018","volume":"38","author":"OR Tamtaji","year":"2019","unstructured":"Tamtaji OR, Taghizadeh M, Daneshvar Kakhaki R, Kouchaki E, Bahmani F, Borzabadi S, et al. Clinical and metabolic response to probiotic administration in people with Parkinson\u2019s disease: A randomized, double-blind, placebo-controlled trial. Clin Nutr 2019, 38: 1031\u20131035.","journal-title":"Clin Nutr"},{"key":"1498_CR109","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.gpb.2021.08.009","volume":"20","author":"A Becker","year":"2022","unstructured":"Becker A, Schmartz GP, Gr\u00f6ger L, Grammes N, Galata V, Philippeit H, et al. Effects of resistant starch on symptoms, fecal markers, and gut microbiota in Parkinson\u2019s disease - the RESISTA-PD trial. Genom Proteom Bioinform 2022, 20: 274\u2013287.","journal-title":"Genom Proteom Bioinform"},{"key":"1498_CR110","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/cells9020376","volume":"9","author":"T Hegelmaier","year":"2020","unstructured":"Hegelmaier T, Lebbing M, Duscha A, Tomaske L, T\u00f6nges L, Holm JB, et al. Interventional influence of the intestinal microbiome through dietary intervention and bowel cleansing might improve motor symptoms in Parkinson\u2019s disease. Cells 2020, 9: 376.","journal-title":"Cells"},{"key":"1498_CR111","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3945\/jn.109.104638","volume":"139","author":"L Peng","year":"2009","unstructured":"Peng L, Li ZR, Green RS, Holzman IR, Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 2009, 139: 1619\u20131625.","journal-title":"J Nutr"},{"key":"1498_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1242\/dmm.017400","volume":"8","author":"TLA Nguyen","year":"2015","unstructured":"Nguyen TLA, Vieira-Silva S, Liston A, Raes J. How informative is the mouse for human gut microbiota research? Dis Model Mech 2015, 8: 1\u201316.","journal-title":"Dis Model Mech"},{"key":"1498_CR113","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5409\/wjcp.v10.i5.84","volume":"10","author":"LB Zhu","year":"2021","unstructured":"Zhu LB, Zhang YC, Huang HH, Lin J. Prospects for clinical applications of butyrate-producing bacteria. World J Clin Pediatr 2021, 10: 84\u201392.","journal-title":"World J Clin Pediatr"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-025-01498-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-025-01498-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-025-01498-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:02:03Z","timestamp":1767992523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-025-01498-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1498"],"URL":"https:\/\/doi.org\/10.1007\/s12264-025-01498-x","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"7 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}